- Category: Press Releases
- 05 October 2013
ICUS Creates Summary Guidelines for Use of Ultrasound Contrast Agents
The International Contrast Ultrasound Society (ICUS) announced today the publication of 'The Standards and Guidelines for Suboptimal Imaging - Summary for Use of Contrast Agents'.
Developed in response to demand for a single document that summarizes all materials related to the use of ultrasound contrast agents, the document includes all relevant standards and guidelines as promulgated by the Intersocietal Accreditation Commission (IAC).
Following greatly increased awareness of the safety and clinical benefits of contrast enhanced ultrasound (CEUS) imaging, and the dangers of radiation associated with certain other forms of imaging, the ICUS Board decided that a utilitarian document was needed to help echocardiography laboratories across the United States standardize their CEUS practices and procedures in accordance with IAC standards and guidelines. "We see the guidelines as an important tool to improve echocardiography," said Steven B. Feinstein, MD, ICUS Co-president and Professor of Medicine at Rush University Medical Center in Chicago.
The Summary includes all IAC references, plus a template for the written echo laboratory protocol required by IAC standards. "The template and draft patient consent forms give providers an excellent guidepost for this revolutionary diagnostic imaging technique," added Michael Main, MD, a member of the ICUS Board and Medical Director of the Echocardiography Laboratory at St. Luke's Mid-America Heart and Vascular Institute in Kansas City.
While the ultrasound contrast agents Definity (Lantheus Medical Imaging) and Optison (GE Healthcare) are only approved for use in the United States for cardiac imaging, they and other ultrasound contrast agents are used widely in Europe and elsewhere for imaging tumors and organ systems throughout the body. Additional applications of these agents are under review worldwide.
Additional versions of the Summary are planned to include the use of other ultrasound contrast agents where approved by local governments around the world.